Oral cavity adjuvant therapy (OCAT) -a phase III, randomized controlled trial of surgery followed by conventional RT (5 fr/wk) versus concurrent CT-RT versus accelerated RT (6fr/wk) in locally advanced, resectable, squamous cell carcinoma of oral cavitySarbani Ghosh Laskar, D'Cruz Anil, Jai Prakash Agarwal et al.|European Journal of Cancer|2022Cited by 29
Clinical outcomes for nasopharyngeal cancer with intracranial extension after taxane‐based induction chemotherapy and concurrent chemo‐radiotherapy in the modern eraSarbani Ghosh‐Laskar, Anil D’Cruz, Avinash Pilar et al.|World Journal of Otorhinolaryngology - Head and Neck Surgery|2020Cited by 3
Nimotuzumab in the treatment of patients with locally advanced HPV-negative oropharyngeal cancer in Indian setting: A health-economic evaluationVanita Noronha, Kumar Prabhash, Vijay Patil et al.|Cancer Research Statistics and Treatment|2025Cited by 0